Search Within

Michael Morris

Formats
  1. Meeting Abstract (275)
  2. Journal Article (268)
  3. Review (19)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (584)
  2. Genitourinary Oncology Service (584)
  3. Solid Tumor Oncology Division (584)
  4. Radiology, Department of (164)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (141)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (25)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (240)
  2. Journal of Nuclear Medicine (44)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (250)
  2. Society of Nuclear Medicine (44)
  3. American Association for Cancer Research (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (40)
  6. Elsevier Inc. (27)

More Publishers

Results (584)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radium-223 safety, efficacy, and concurrent use with abiraterone or enzalutamide: First U.S. experience from an expanded access program
    Journal Article

    Sartor, O.; Vogelzang, N. J.; Sweeney, C.; Fernandez, D. C.; Almeida, F.; Iagaru, A.; Brown, A. Jr; Smith, M. R.; Agrawal, M.; Dicker, A. P.; more...
    The Oncologist (2018)

    Fulltext@MSK | Save
  • Current perspectives on bone metastases in castrate-resistant prostate cancer
    Journal Article

    Logothetis, C.; Morris, M. J.; Den, R.; Coleman, R. E.
    Cancer and Metastasis Reviews (2018)

    Fulltext@MSK | Save
  • Naming disease states for clinical utility in prostate cancer: A rose by any other name might not smell as sweet
    Journal Article

    Armstrong, A. J.; Antonarakis, E. S.; Taplin, M. E.; Kelly, W. K.; Beltran, H.; Fizazi, K.; Dahut, W. L.; Shore, N.; Slovin, S.; George, D.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Management of patients with advanced prostate cancer: The report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
    Journal Article

    Gillessen, S.; Attard, G.; Beer, T. M.; Beltran, H.; Bossi, A.; Bristow, R.; Carver, B.; Castellano, D.; Chung, B. H.; Clarke, N.; more...
    European Urology (2018)

    Fulltext@MSK | Save
  • Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Journal Article

    Abida, W.; Armenia, J.; Gopalan, A.; Brennan, R.; Walsh, M.; Barron, D.; Danila, D.; Rathkopf, D.; Morris, M.; Slovin, S.; more...
    JCO Precision Oncology (2017)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTCs) N-terminal androgen receptor expression to identify patients (pts) with castrate resistant prostate cancer (CRPC) who are more sensitive to chemotherapy
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Carbone, E.; Fernandez, C.; Chen, Y.; Autio, K. A.; Rathkopf, D. E.; Kampel, L.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical versus radiographic progression and overall survival for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) from COU-AA-302
    Meeting Abstract

    Ryan, C. J.; Kheoh, T.; Scher, H. I.; De Porre, P.; Yu, M. K.; Morris, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1 study of the PSMA-targeted small-molecule drug conjugate EC1 169 in patients with metastatic castrate-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Vogelzang, N.; Sartor, O.; Armour, A.; Groaning, M.; Robarts, A.; Petrylak, D. P.; Tolcher, A. W.; Gordon, M. S.; Babiker, H. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II trial of abiraterone acetate (AA) without prednisone in castration resistant prostate cancer (CRPC)
    Meeting Abstract

    McKay, R. R.; Werner, L.; Jones, A.; Choudhury, A. D.; Pomerantz, M.; Sweeney, C.; Bubley, G. J.; Slovin, S. F.; Morris, M. J.; Kantoff, P. W.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Association of on-treatment plasma HGF levels with overall survival (OS) in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (INF) +/- bevacizumab (BEV): Results from CALGB 90206 (Alliance)
    Meeting Abstract

    George, D. J.; Halabi, S.; Starr, M. D.; Hurwitz, H.; Brady, J. C.; Barak, I.; Morris, M. J.; Rini, B. I.; Small, E. J.; Kim, W.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save